|
1
|
Savage SA and Mirabello L: Using
epidemiology and genomics to understand osteosarcoma etiology.
Sarcoma. 2011:5481512011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhao H, Yao Y, Wang Z, Lin F, Sun Y and
Chen P: Therapeutic effect of pirarubicin-based chemotherapy for
osteosarcoma patients with lung metastasis. J Chemother. 22(2):
119–124. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He A, Yang X, Huang Y, Feng T, Wang Y, Sun
Y, Shen Z and Yao Y: CD133(+) CD44(+) cells mediate in the lung
metastasis of osteosarcoma. J Cell Biochem. 116:1719–1729. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tang N, Song WX, Luo J, Haydon RC and He
TC: Osteosarcoma development and stem cell differentiation. Clin
Orthop Relat Res. 466:2114–2130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Daw NC, Chou AJ, Jaffe N, Rao BN, Billups
CA, Rodriguez-Galindo C, Meyers PA and Huh WW: Recurrent
osteosarcoma with a single pulmonary metastasis: A
multi-institutional review. Br J Cancer. 112:278–282. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Marina N, Gebhardt M, Teot L and Gorlick
R: Biology and therapeutic advances for pediatric osteosarcoma.
Oncologist. 9:422–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Salunke AA, Chen Y, Tan JH, Chen X, Khin
LW and Puhaindran ME: Does a pathological fracture affect the
prognosis in patients with osteosarcoma of the extremities?: A
systematic review and meta-analysis. Bone Joint J. 96-B:1396–1403.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Munajat I, Zulmi W, Norazman MZ and Wan
Faisham WI: Tumour volume and lung metastasis in patients with
osteosarcoma. J Orthop Surg (Hong Kong). 16:182–185. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Xu Y, Lin N, Jiang S, Wang Y and Ye
Z: High-dose methotrexate (HD-MTX) used as an adjunct with other
chemotherapeutics for the treatment of osteosarcoma. Cell Biochem
Biophys. 71:1097–1104. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu W, Tang L, Lin F, Yao Y, Shen Z and
Zhou X: High-intensity focused ultrasound: Noninvasive treatment
for local unresectable recurrence of osteosarcoma. Surg Oncol.
24:9–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faisham WI, Mat Saad AZ, Alsaigh LN, Nor
Azman MZ, Kamarul Imran M, Biswal BM, Bhavaraju VM, Salzihan MS,
Hasnan J, Ezane AM, et al: Prognostic factors and survival rate of
osteosarcoma: A single-institution study. Asia Pac J Clin Oncol.
13:e104–e110. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fu HL, Shao L, Wang Q, Jia T, Li M and
Yang DP: A systematic review of p53 as a biomarker of survival in
patients with osteosarcoma. Tumor Biol. 34:3817–3821. 2013.
View Article : Google Scholar
|
|
13
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment-Where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lendeckel D, Eymann C, Emicke P,
Daeschlein G, Darm K, O'Neil S, Beule AG, von Woedtke T, Völker U,
Weltmann KD, et al: Proteomic Changes of Tissue-tolerable plasma
treated airway epithelial cells and their relation to wound
healing. Biomed Res Int. 2015:5060592015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weiss M, Gümbel D, Hanschmann EM,
Mandelkow R, Gelbrich N, Zimmermann U, Walther R, Ekkernkamp A,
Sckell A, Kramer A, et al: Cold atmospheric plasma treatment
induces anti-proliferative effects in prostate cancer cells by
redox and apoptotic signaling pathways. PLoS One. 10:e01303502015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reiazi R, Akbari ME, Norozi A and
Etedadialiabadi M: Application of cold atmospheric plasma (cap) in
cancer therapy: A review. Int J Cancer Manag. 10:e87282017.
View Article : Google Scholar
|
|
17
|
Chen Z, Lin L, Zheng Q, Sherman JS, Canady
J, Trink B and Keidar M: Micro-sized cold atmospheric plasma source
for brain and breast cancer treatment. Plasma Med. 8:203–211. 2018.
View Article : Google Scholar
|
|
18
|
Gümbel D, Gelbrich N, Weiss M, Napp M,
Daeschlein G, Sckell A, Ender SA, Kramer A, Burchardt M, Ekkernkamp
A and Stope MB: New treatment options for osteosarcoma-inactivation
of osteosarcoma cells by cold atmospheric plasma. Anticancer Res.
36:5915–5922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gümbel D, Gelbrich N, Napp M, Daeschlein
G, Kramer A, Sckell A, Burchardt M, Ekkernkamp A and Stope MB:
Peroxiredoxin expression of human osteosarcoma cells is influenced
by cold atmospheric plasma treatment. Anticancer Res. 37:1031–1038.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koensgen D, Besic I, Gümbel D, Kaul A,
Weiss M, Diesing K, Kramer A, Bekeschus S, Mustea A and Stope MB:
Cold atmospheric plasma (CAP) and CAP-stimulated cell culture media
suppress ovarian cancer cell growth-a putative treatment option in
ovarian cancer therapy. Anticancer Res. 37:6739–6744.
2017.PubMed/NCBI
|
|
21
|
Gümbel D, Bekeschus S, Gelbrich N, Napp M,
Ekkernkamp A, Kramer A and Stope MB: Cold atmospheric plasma in the
treatment of osteosarcoma. Int J Mol Sci. 18(pii): E20042017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gümbel D, Daeschlein G, Ekkernkamp A,
Kramer A and Stope MB: Cold atmospheric plasma in orthopaedic and
urologic tumor therapy. GMS Hyg Infect Control.
12:Doc102017.PubMed/NCBI
|
|
23
|
Weiss M, Daeschlein G, Kramer A, Burchardt
M, Brucker S, Wallwiener D and Stope MB: Virucide properties of
cold atmospheric plasma for future clinical applications. J Med
Virol. 89:952–959. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Schmidt A, Bekeschus S, von Woedtke T and
Hasse S: Cell migration and adhesion of a human melanoma cell line
is decreased by cold plasma treatment. Clin Plasma Med. 3:24–31.
2015. View Article : Google Scholar
|
|
25
|
Haralambiev L, Wien L, Gelbrich N, Kramer
A, Mustea A, Burchardt M, Ekkernkamp A, Stope MB and Gümbel D:
Effects of cold atmospheric plasma on the expression of chemokines,
growth factors, TNF superfamily members, interleukins, and
cytokines in human osteosarcoma cells. Anticancer Res. 39:151–157.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Strober W: Trypan blue exclusion test of
cell viability. Curr Protoc Immunol. 111:A3.B.1–3. 2015. View Article : Google Scholar
|
|
27
|
Daeschlein G, Scholz S, Arnold A, von
Podewils S, Haase H, Emmert S, von Woedtke T, Weltmann KD and
Juenger M: In vitro susceptibility of important skin and wound
pathogens against low temperature atmospheric pressure plasma jet
(APPJ) and dielectric barrier discharge plasma (DBD). Plasma
Processes Polymers. 9:380–389. 2012. View Article : Google Scholar
|
|
28
|
Assadian O, Ousey KJ, Daeschlein G, Kramer
A, Parker C, Tanner J and Leaper DJ: Effects and safety of
atmospheric low-temperature plasma on bacterial reduction in
chronic wounds and wound size reduction: A systematic review and
meta-analysis. Int Wound J. 16:103–111. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bernhardt T, Semmler ML, Schäfer M,
Bekeschus S, Emmert S and Boeckmann L: Plasma medicine:
Applications of cold atmospheric pressure plasma in dermatology.
Oxid Med Cell Longev. 2019:38739282019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lunov O, Zablotskii V, Churpita O, Chánová
E, Syková E, Dejneka A and Kubinová S: Cell death induced by ozone
and various non-thermal plasmas: Therapeutic perspectives and
limitations. Sci Rep. 4:71292014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Vandamme M, Robert E, Lerondel S, Sarron
V, Ries D, Dozias S, Sobilo J, Gosset D, Kieda C, Legrain B, et al:
ROS implication in a new antitumor strategy based on non-thermal
plasma. Int J Cancer. 130:2185–2194. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Graves DB: Reactive species from cold
atmospheric plasma: Implications for cancer therapy. Plasma Process
Polym. 11:1120–1127. 2014. View Article : Google Scholar
|
|
33
|
Hirst AM, Simms MS, Mann VM, Maitland NJ,
O'Connell D and Frame FM: Low-temperature plasma treatment induces
DNA damage leading to necrotic cell death in primary prostate
epithelial cells. Br J Cancer. 112:1536–1545. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weiss M, Gümbel D, Gelbrich N, Brandenburg
LO, Mandelkow R, Zimmermann U, Ziegler P, Burchardt M and Stope MB:
Inhibition of cell growth of the prostate cancer cell model LNCaP
by Cold Atmospheric Plasma. In Vivo. 29:611–116. 2015.PubMed/NCBI
|
|
35
|
Binenbaum Y, Ben-David G, Gil Z, Slutsker
YZ, Ryzhkov MA, Felsteiner J, Krasik YE and Cohen JT: Cold
atmospheric plasma, created at the tip of an elongated flexible
capillary using low electric current, can slow the progression of
Melanoma. PLoS One. 12:e01694572017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hattori N, Yamada S, Torii K, Takeda S,
Nakamura K, Tanaka H, Kajiyama H, Kanda M, Fujii T, Nakayama G, et
al: Effectiveness of plasma treatment on pancreatic cancer cells.
Int J Oncol. 47:1655–1662. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gümbel D, Suchy B, Wien L, Gelbrich N,
Napp M, Kramer A, Ekkernkamp A, Daeschlein G and Stope MB:
Comparison of cold atmospheric plasma Devices' efficacy on
osteosarcoma and fibroblastic in vitro cell models. Anticancer Res.
37:5407–5414. 2017.PubMed/NCBI
|
|
38
|
Winter J, Brandenburg R and Weltmann KD:
Atmospheric pressure plasma jets: An overview of devices and new
directions. Plasma Sources Sci Technol. 24:192015. View Article : Google Scholar
|
|
39
|
Laroussi M and Akan T: Arc-free
atmospheric pressure cold plasma jets: A review. Plasma Process
Polym. 4:777–788. 2007. View Article : Google Scholar
|
|
40
|
Schmidt-Bleker A, Bansemer R, Reuter S and
Weltmann KD: How to produce an NOx-instead of Ox-based chemistry
with a cold atmospheric plasma jet. Plasma Process Polym.
13:120–1127. 2016. View Article : Google Scholar
|
|
41
|
Siu A, Volotskova O, Cheng X, Khalsa SS,
Bian K, Murad F, Keidar M and Sherman JH: Differential effects of
cold atmospheric plasma in the treatment of malignant glioma. PLoS
One. 10:e01263132015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nguyen NH, Park HJ, Yang SS, Choi KS and
Lee JS: Anti-cancer efficacy of nonthermal plasma dissolved in a
liquid, liquid plasma in heterogeneous cancer cells. Sci Rep.
6:290202016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ishaq M, Kumar S, Varinli H, Han ZJ, Rider
AE, Evans MD, Murphy AB and Ostrikov K: Atmospheric gas
plasma-induced ROS production activates TNF-ASK1 pathway for the
induction of melanoma cancer cell apoptosis. Mol Biol Cell.
25:1523–1531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ma Y, Ha CS, Hwang SW, Lee HJ, Kim GC, Lee
KW and Song K: Non-thermal atmospheric pressure plasma
preferentially induces apoptosis in p53-mutated cancer cells by
activating ROS stress-response pathways. PLoS One. 9:e919472014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kang SU, Cho JH, Chang JW, Shin YS, Kim
KI, Park JK, Yang SS, Lee JS, Moon E, Lee K and Kim CH: Nonthermal
plasma induces head and neck cancer cell death: The potential
involvement of mitogen-activated protein kinase-dependent
mitochondrial reactive oxygen species. Cell Death Dis. 5:e10562014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Arjunan KP, Sharma VK and Ptasinska S:
Effects of atmospheric pressure plasmas on isolated and cellular
DNA-a review. Int J Mol Sci. 16:2971–3016. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kluge S, Bekeschus S, Bender C, Benkhai H,
Sckell A, Below H, Stope MB and Kramer A: Investigating the
mutagenicity of a cold argon-plasma jet in an HET-MN Model. PLoS
One. 11:e01606672016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Strassenburg S, Greim U, Bussiahn R,
Haertel B, Wende K, Woedtke T and Lindequist U: Comparison of
biological effects on human keratinocytes using different plasma
treatment regimes. Plasma Med. 3:57–69. 2013. View Article : Google Scholar
|
|
49
|
Bekeschus S, Schütz CS, Nießner F, Wende
K, Weltmann KD, Gelbrich N, Woedtke T, Schmidt A and Stope MB:
Elevated H2AX phosphorylation observed with kINPen plasma treatment
is not caused by ROS-mediated DNA damage but is the consequence of
apoptosis. Oxid Med Cell Longev. 2019:85351632019. View Article : Google Scholar : PubMed/NCBI
|
